140 related articles for article (PubMed ID: 19475990)
1. Structure activity studies on the crinane alkaloid apoptosis-inducing pharmacophore.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Nat Prod Commun; 2009 Apr; 4(4):483-8. PubMed ID: 19475990
[TBL] [Abstract][Full Text] [Related]
2. Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Codina C; Bastida J; Pandey S; Gerasimoff J; Griffin C
Phytochemistry; 2007 Apr; 68(7):1068-74. PubMed ID: 17331551
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells.
McNulty J; Nair JJ; Bastida J; Pandey S; Griffin C
Phytochemistry; 2009 May; 70(7):913-9. PubMed ID: 19464034
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimalarial activity of new haemanthamine-type derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo ÁG; Estévez-Braun A
Bioorg Med Chem; 2012 Sep; 20(18):5464-72. PubMed ID: 22910226
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiplasmodial activity of lycorine derivatives.
Cedrón JC; Gutiérrez D; Flores N; Ravelo AG; Estévez-Braun A
Bioorg Med Chem; 2010 Jul; 18(13):4694-701. PubMed ID: 20627737
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae.
Nair JJ; Rárová L; Strnad M; Bastida J; van Staden J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6195-9. PubMed ID: 22921081
[TBL] [Abstract][Full Text] [Related]
7. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells.
Van Goietsenoven G; Andolfi A; Lallemand B; Cimmino A; Lamoral-Theys D; Gras T; Abou-Donia A; Dubois J; Lefranc F; Mathieu V; Kornienko A; Kiss R; Evidente A
J Nat Prod; 2010 Jul; 73(7):1223-7. PubMed ID: 20550100
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.
Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R
J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids.
Nair JJ; van Staden J
Nat Prod Commun; 2012 Jul; 7(7):959-62. PubMed ID: 22908593
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic agents of the crinane series of amaryllidaceae alkaloids.
Nair JJ; Bastida J; Viladomat F; van Staden J
Nat Prod Commun; 2012 Dec; 7(12):1677-88. PubMed ID: 23413581
[TBL] [Abstract][Full Text] [Related]
11. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells.
Havelek R; Seifrtova M; Kralovec K; Bruckova L; Cahlikova L; Dalecka M; Vavrova J; Rezacova M; Opletal L; Bilkova Z
Phytomedicine; 2014 Mar; 21(4):479-90. PubMed ID: 24182986
[TBL] [Abstract][Full Text] [Related]
12. Lycorine derivatives against Trichomonas vaginalis.
Giordani RB; Junior CO; de Andrade JP; Bastida J; Zuanazzi JA; Tasca T; de Almeida MV
Chem Biol Drug Des; 2012 Jul; 80(1):129-33. PubMed ID: 22260620
[TBL] [Abstract][Full Text] [Related]
13. C1,C2-ether derivatives of the Amaryllidaceae alkaloid lycorine: retention of activity of highly lipophilic analogues against cancer cells.
Dasari R; Banuls LM; Masi M; Pelly SC; Mathieu V; Green IR; van Otterlo WA; Evidente A; Kiss R; Kornienko A
Bioorg Med Chem Lett; 2014 Feb; 24(3):923-7. PubMed ID: 24393582
[TBL] [Abstract][Full Text] [Related]
14. Phytochemical and biological investigation of Hymenocallis littoralis SALISB.
Abou-Donia AH; Toaima SM; Hammoda HM; Shawky E; Kinoshita E; Takayama H
Chem Biodivers; 2008 Feb; 5(2):332-40. PubMed ID: 18293433
[TBL] [Abstract][Full Text] [Related]
15. Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.
McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC; Bastida J
Bioorg Med Chem Lett; 2009 Jun; 19(12):3233-7. PubMed ID: 19428250
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Structure-Activity Relationship Optimization of Lycorine Derivatives for HCV Inhibition.
Chen D; Cai J; Cheng J; Jing C; Yin J; Jiang J; Peng Z; Hao X
Sci Rep; 2015 Oct; 5():14972. PubMed ID: 26443922
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 3A4 inhibitory activity studies within the lycorine series of alkaloids.
McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC; Bastida J
Nat Prod Commun; 2010 Aug; 5(8):1195-200. PubMed ID: 20839617
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative alkaloids from Crinum zeylanicum.
Berkov S; Romani S; Herrera M; Viladomat F; Codina C; Momekov G; Ionkova I; Bastida J
Phytother Res; 2011 Nov; 25(11):1686-92. PubMed ID: 21442675
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Amaryllidaceae alkaloids from Crinum by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Zhang X; Huang H; Liang X; Huang H; Dai W; Shen Y; Yan S; Zhang W
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2903-16. PubMed ID: 19670339
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Structural Optimization of Lycorine-Derived Phenanthridine Derivatives as Wnt/β-Catenin Signaling Pathway Agonists.
Chen DZ; Jing CX; Cai JY; Wu JB; Wang S; Yin JL; Li XN; Li L; Hao XJ
J Nat Prod; 2016 Jan; 79(1):180-8. PubMed ID: 26714198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
